Movers roundup: Avant, Cypress Semiconductor (AP)
Shares of Avant Immunotherapeutics Inc. are climbing after the company licensed a cancer vaccine candidate to drug developer Pfizer.
Shares of Avant Immunotherapeutics Inc. are climbing after the company licensed a cancer vaccine candidate to drug developer Pfizer.
Similar/Related/News: